- The increasing demand for the Cataract Surgery Device Market is because of an increase in cataract disorders prevalence, technical developments in ophthalmic products and an increasing geriatric population
LAS VEGAS, April 22, 2021 /PRNewswire/ -- DelveInsight's 'Cataract Surgery Devices Market, Competitive Landscape and Market Forecast till 2026' report delivers an overview of Cataract Surgery Devices and the historical and forecasted Cataract Surgery Devices market trends in seven major markets namely the United States, Europe [Germany, France, Italy, Spain, the United Kingdom], and Japan. The Cataract Surgery Devices Competitive report also proffers an analysis of the market drivers, market barriers, and unmet medical needs along with a PEST analysis of the market.
The major companies active in the Cataract Surgery Devices market include Johnson & Johnson, Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International Inc., Ziemer Ophthalmic Systems AG, and many others.
The very first trifocal lens for cataract surgery patients has been approved by the FDA. The AcrySof IQ PanOptix Trifocal Intraocular lens (IOL) is now available to cataract patients in the United States for the first time.
Recently, many femtosecond lasers have been approved by the FDA for being used in cataract surgery performed in the United States.
DelveInsight anticipates a higher Cataract Surgery Devices Market share of the United States as compared to other countries.
The Cataract Surgery Devices market demand is propelled by an increase in cataract disorders prevalence, technical developments in ophthalmic products, and an increasing geriatric population. However, the high costs associated with cataract surgery, especially in developing economies, are limiting the Cataract Surgery Devices market growth.
Cataract Surgery is a procedure that involves the removal of the lens from the eye, and in most scenarios, the lens is replaced with an artificial lens. This surgery is performed for cataract treatment.
Cataract surgery often involves using a high-frequency ultrasound device that causes the breaking of the lens into various small pieces, which are then gently removed from the eye area using suction force. The procedure is also known as phacoemulsification and can be performed with smaller incisions, ensuring faster healing. After removing all the remnants from the eye area, the cataract surgeon inserts an intraocular lens placing it safely behind the iris and pupil, at the exact location where the natural lens was placed.
The Cataract Surgery Devices are segmented according to the Product Type-
Intraocular Lens (IOL)
Ophthalmic Viscoelastic Device (OVD)
Femtosecond Laser Equipment.
Intraocular Lens (IOL)
An intraocular lens implant is an artificial replacement for the natural lens of your eye. It is a significant part of the surgery that can be used in fixing cataracts. An intraocular lens, also known as the intraocular implant, is made of clear plastic. There are multiple types of Intraocular lenses- Monofocal IOL, Multifocal implant, and Accommodating IOL.
Ophthalmic Viscoelastic Device (OVD)
Ophthalmic Viscological Devices are gel-like, transparent substances that carry viscous and elastic properties. They are used extensively in modern intraocular procedures and used routinely in cataract surgeries for protecting delicate ocular structures and provide a faster surgery with better visual recovery for the patients. Apart from the various viscoelastic substances, sodium hyaluronate is the most commonly used biopolymer used in Ophthalmic Viscoelastic Devices for intraocular surgery. Albomed introduced their latest innovation in the field of sodium hyaluronate OVDs named Pe-Ha-Blue PLUS, which combines the viscoelastic properties of Pe-Ha-Luron F with trypan blue.
The Cataract Surgery Devices are segmented according to the surgery types-
Extracapsular Cataract Extraction (Ecce) Surgery
Femtosecond Laser Surgery
The Cataract Surgery Devices Market is segmented as End User into-
TECNIS® Multifocal Intraocular Lenses, (+3.25 D): The TECNIS Multifocal 1-Piece intraocular lenses, (+3.25 D), are designated for primary implantation for the visual correction of aphakia in adult patients with and without presbyopia in whom a cataractous lens has been eliminated by phacoemulsification and who need near, intermediate, and distance vision with increased spectacle independence. The TECNIS Multifocal Family of 1-Piece IOLs presents the only multifocal lenses capable of proffering a complete range of high-quality vision (20/25 or better),1,2 customised for each patient's lifestyle.
The TECNIS Multifocal 1-Piece intraocular lenses (+3.25 D) offer cataract patients with options to have a complete range of near, intermediate, and distant vision, with a treatment customised to fulfil their personal requirements and lifestyle. The +3.25 D IOL is ideal for people performing longer reading distances, such as reading a hand-held device.
Geography Covered: The United States, Europe [Germany, France, Italy, Spain, the United Kingdom,], and Japan.
Study Period: 3-year historical and 8-year forecasted analysis (2018-2026).
Cataract Surgery Devices Markets Segmentation: By Geographies, By Product Type, By Surgery Type
Dominant Market Companies investigating its candidates for Cataract Surgery Devices: Johnson & Johnson, Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International Inc., Ziemer Ophthalmic Systems AG, and several others.
DelveInsight's Cataract Surgery Complications Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Cataract Surgery Complications.
Cataract Surgery Complications Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Cataract Surgery Complications market.
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.